Research Article
Prevalence and Risk Factors of Gastric Adenoma and Gastric Cancer in Colorectal Cancer Patients
Table 3
Comparison of baseline characteristics and endoscopic findings in the subjects with colorectal cancer patients and control group.
| | Variables | Colorectal cancer patients () | Control group
() | value |
| | Sex | | | 0.105 | | Male | 91 (64.1%) | 240 (56.3%) | | | Female | 51 (35.9%) | 186 (43.7%) | | | Age (yrs) | 65.63 ± 10.98 | 61.87 ± 9.99 | 0.184 | | Body weight (kg) | 59.06 ± 9.23 | 64.67 ± 11.02 | 0.023 | | BMI (body mass index, kg/m2) | 22.71 ± 3.03 | 23.97 ± 3.29 | 0.583 | | Hypertension | 45 (31.7%) | 110 (25.8%) | 0.174 | | Diabetes | 29 (20.4%) | 55 (12.9%) | 0.029 | | Smoking | 33 (23.2%) | 71 (16.7%) | 0.079 | | Alcohol | 45 (31.7%) | 162 (38.0%) | 0.174 | | Family history (solid tumor) | 16 (11.3%) | 103 (24.2%) | 0.001 | | Follow-up period (months) | 28.3 ± 25.11 | 44.4 ± 25.37 | 0.577 | | Baseline endoscopic findings | | | | | Chronic atrophic gastritis | 80 (56.3%) | 267 (62.7%) | 0.180 | | Intestinal metaplasia | 15 (10.6%) | 24 (5.6%) | 0.044 | | Gastric ulcer | 2 (1.4%) | 4 (0.9%) | 0.636 | | Duodenal ulcer | 3 (2.1%) | 8 (1.9%) | 0.860 | | Hyperplastic polyp | 2 (1.4%) | 20 (4.7%) | 0.079 | | Gastric adenoma | 3 (2.1%) | 7 (1.6%) | 0.713 | | Gastric cancer | 10 (7.0%) | 2 (0.5%) | <0.001 | | Subepithelial tumor (SET) | 3 (2.1%) | 0 (0%) | 0.003 |
|
|
